The impact of obesity-related raised intracranial pressure in rodents.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
received:
06
10
2021
accepted:
06
05
2022
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Elevated intracranial pressure (ICP) is observed in many brain disorders. Obesity has been linked to ICP pathogenesis in disorders such as idiopathic intracranial pressure (IIH). We investigated the effect of diet induced obesity (DIO) on ICP and clinically relevant sequelae. Rats were fed either a control or high fat diet. Following weight gain long term ICP, headache behavior, body composition and retinal outcome were examined. Post-hoc analysis of retinal histology and molecular analysis of choroid plexus and trigeminal ganglion (TG) were performed. DIO rats demonstrated raised ICP by 55% which correlated with the abdominal fat percentage and increased non-respiratory slow waves, suggestive of altered cerebral compliance. Concurrently, DIO rats demonstrated a specific cephalic cutaneous allodynia which negatively correlated with the abdominal fat percentage. This sensitivity was associated with increased expression of headache markers in TG. Additionally, DIO rats had increased retinal nerve fiber layer thickness in vivo associated with raised ICP with a subsequent post-hoc demonstration of neuroretinal degeneration. This study demonstrates for the first time that DIO leads to raised ICP and subsequent clinically relevant symptom development. This novel model of non-traumatic raised ICP could expand the knowledge regarding disorders with elevated ICP such as IIH.
Identifiants
pubmed: 35650312
doi: 10.1038/s41598-022-13181-6
pii: 10.1038/s41598-022-13181-6
pmc: PMC9160066
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9102Informations de copyright
© 2022. The Author(s).
Références
JCI Insight. 2021 May 24;6(10):
pubmed: 33848268
Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):445-6
pubmed: 21814821
Handb Clin Neurol. 2017;146:171-185
pubmed: 29110769
BMC Neurosci. 2011 Nov 10;12:112
pubmed: 22074408
J Comp Neurol. 2004 Oct 4;478(1):62-71
pubmed: 15334649
J Neurosurg. 2014 Oct;121(4):797-801
pubmed: 24702326
Neuroscience. 2016 Sep 7;331:99-108
pubmed: 27328418
J Headache Pain. 2020 Feb 4;21(1):9
pubmed: 32019484
Int J Obes (Lond). 2017 Jul;41(7):1141-1147
pubmed: 28344346
Cephalalgia. 2018 Mar;38(3):452-465
pubmed: 28952321
Headache. 2010 Jan;50(1):52-62
pubmed: 19496830
Nat Rev Endocrinol. 2013 Jan;9(1):13-27
pubmed: 23165161
J Pain. 2013 Nov;14(11):1289-303
pubmed: 23958278
Neuroscience. 2013 Apr 3;235:87-95
pubmed: 23333672
Fluids Barriers CNS. 2019 Nov 26;16(1):35
pubmed: 31767019
Neuroscience. 2010 Aug 25;169(2):683-96
pubmed: 20472035
Fluids Barriers CNS. 2020 Feb 10;17(1):10
pubmed: 32036786
Int J Obes Relat Metab Disord. 1999 Jan;23(1):54-9
pubmed: 10094577
Neurology. 2007 May 22;68(21):1851-61
pubmed: 17515549
J Headache Pain. 2021 Oct 10;22(1):123
pubmed: 34629054
Fluids Barriers CNS. 2020 Jun 9;17(1):39
pubmed: 32517699
Trends Mol Med. 2010 Apr;16(4):153-9
pubmed: 20347391
Brain Res. 2015 Mar 10;1600:93-109
pubmed: 25463029
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
FASEB J. 2005 Jan;19(1):76-8
pubmed: 15533949
Eur J Neurol. 2014 Dec;21(12):1458-64
pubmed: 25070715
Pain. 2016 Jan;157(1):235-246
pubmed: 26397933
Curr Pain Headache Rep. 2012 Feb;16(1):101-9
pubmed: 22076673
Neuroscience. 2010 Jul 28;168(4):941-56
pubmed: 19761815
Headache. 2017 Sep;57(8):1195-1205
pubmed: 28752894
J Appl Physiol (1985). 2015 Sep 1;119(5):576-81
pubmed: 26159754
Exp Eye Res. 2015 Jul;136:38-44
pubmed: 25912998
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4487-98
pubmed: 26193926
Eye (Lond). 2019 Mar;33(3):478-485
pubmed: 30356129
PLoS One. 2014 Dec 11;9(12):e114546
pubmed: 25501362
Sci Rep. 2018 Feb 12;8(1):2856
pubmed: 29434244
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Expert Opin Ther Targets. 2007 Mar;11(3):307-20
pubmed: 17298290
Cell Rep. 2020 Dec 22;33(12):108524
pubmed: 33357428
J Pharmacol Toxicol Methods. 2016 Jul-Aug;80:43-50
pubmed: 27066766
Lipids Health Dis. 2010 Dec 09;9:140
pubmed: 21143884
Invest Ophthalmol Vis Sci. 2012 Mar 15;53(3):1422-7
pubmed: 22323469
Lancet. 2019 Nov 9;394(10210):1765-1774
pubmed: 31668411
BMJ Open. 2014 Apr 08;4(4):e004376
pubmed: 24713214
Obes Surg. 2019 Jul;29(7):2174-2179
pubmed: 30864103
Acta Neurochir (Wien). 2015 Jan;157(1):109-13
pubmed: 25307778
Front Neurol. 2019 Aug 16;10:899
pubmed: 31474937
Eur J Neurol. 2012 Jan;19(1):155-62
pubmed: 22175760
J Neuroophthalmol. 2013 Mar;33(1):4-8
pubmed: 22217456
J Neurosci Methods. 2014 Apr 30;227:1-9
pubmed: 24521617
Clin Neurol Neurosurg. 2020 Jan;188:105597
pubmed: 31778875
Sci Rep. 2018 Jan 30;8(1):1836
pubmed: 29382888
Neurology. 2002 May 28;58(10):1551-3
pubmed: 12034799
J Neurosci. 2009 Apr 15;29(15):4981-92
pubmed: 19369567
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4564-72
pubmed: 17898279
World Neurosurg. 2018 Feb;110:e119-e123
pubmed: 29107158